| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
29,268 |
24,332 |
$1.63M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
16,135 |
13,308 |
$438K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
3,704 |
3,153 |
$360K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
6,841 |
5,782 |
$273K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
4,967 |
4,229 |
$233K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,629 |
3,099 |
$177K |
| 87634 |
|
1,955 |
1,644 |
$136K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,971 |
1,602 |
$88K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,844 |
1,651 |
$82K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,099 |
745 |
$58K |
| 99381 |
|
1,323 |
830 |
$48K |
| 90648 |
|
2,811 |
2,477 |
$34K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
897 |
563 |
$32K |
| 90670 |
|
2,964 |
2,633 |
$30K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
881 |
663 |
$30K |
| 90723 |
|
2,572 |
2,248 |
$26K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,292 |
1,068 |
$26K |
| 99215 |
Prolong outpt/office vis |
202 |
176 |
$19K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,281 |
1,127 |
$14K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
309 |
239 |
$14K |
| 90633 |
|
1,234 |
1,052 |
$13K |
| 90716 |
|
1,090 |
923 |
$11K |
| 90707 |
|
1,036 |
883 |
$11K |
| T1502 |
Administration of oral, intramuscular and/or subcutaneous medication by health care agency/professional, per visit |
8,082 |
6,811 |
$10K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
17,595 |
10,785 |
$10K |
| 99382 |
|
424 |
226 |
$10K |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
929 |
770 |
$10K |
| 99383 |
|
394 |
215 |
$9K |
| 90680 |
|
727 |
644 |
$7K |
| 90677 |
|
538 |
473 |
$6K |
| 96127 |
|
4,124 |
2,604 |
$6K |
| 90681 |
|
423 |
364 |
$5K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
282 |
261 |
$3K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
381 |
304 |
$3K |
| 83655 |
|
296 |
217 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
277 |
241 |
$3K |
| 90647 |
|
270 |
240 |
$2K |
| 99188 |
|
162 |
117 |
$2K |
| 87807 |
|
141 |
131 |
$2K |
| 90688 |
|
155 |
110 |
$2K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
74 |
44 |
$2K |
| 92552 |
|
84 |
67 |
$1K |
| 69210 |
|
99 |
41 |
$1K |
| 90700 |
|
100 |
91 |
$1K |
| 95117 |
|
83 |
67 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
114 |
97 |
$904.56 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
90 |
71 |
$892.37 |
| 90686 |
|
59 |
56 |
$670.30 |
| 90696 |
|
66 |
58 |
$670.14 |
| 80061 |
Lipid panel |
44 |
31 |
$534.31 |
| 81002 |
|
155 |
129 |
$414.58 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
26 |
19 |
$378.46 |
| 90734 |
|
31 |
25 |
$367.82 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
26 |
25 |
$177.60 |
| 96161 |
|
11,939 |
9,066 |
$65.08 |
| 94664 |
|
46 |
37 |
$13.90 |
| 94760 |
|
34 |
27 |
$8.00 |
| 97802 |
|
2,109 |
1,597 |
$6.00 |
| 96160 |
|
370 |
279 |
$0.00 |
| 99461 |
|
19 |
12 |
$0.00 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
13 |
13 |
$0.00 |
| 36416 |
|
322 |
266 |
$0.00 |